Treatment Selection According to Skin Reaction to Cetuximab
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The therapy of patients with locally advanced head and neck cancer will be adjusted to the
grade of skin rush as recorded after the first two cycles of Cetuximab and Cisplatin, i.e.
either with radioimmunotherapy (radiotherapy and Cetuximab) or radiochemotherapy
(radiotherapy and Cisplatin.